# A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Oesophageal Squamous Cell Carcinoma

- Company: Merck Sharp & Dohme LLC
- Sector: Oesophageal Squamous Cell Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT07405151

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.